Modalities for Healthy Subjects
Trial Summary
Do I need to stop my child's current medications for the trial?
The trial protocol does not specify whether participants must stop taking their current medications.
What data supports the effectiveness of the treatment Modalities for Healthy Subjects?
The research on multimodality imaging systems suggests that combining different imaging techniques can improve diagnostics and therapeutic monitoring by integrating the strengths of each modality. This implies that the treatment modalities being studied may offer enhanced diagnostic and therapeutic capabilities by leveraging the benefits of both 2D and 3D imaging.12345
Is the treatment generally safe for humans?
Gadolinium-based contrast agents, used in MRI scans, have been widely used for 30 years and are generally considered safe, though there have been reports of gadolinium remaining in the brain without known harmful effects. Some people may experience mild reactions, but serious adverse events are rare.678910
What is the purpose of this trial?
The goal of this work is to address increasing concerns about young children's digital media exposure and language outcomes by testing how the times course of word learning unfolds in digital environments and the cascading impact of digital media on vocabulary outcomes. The findings will have important implications for understanding when and where optimal word learning from media can occur.
Eligibility Criteria
This trial is for healthy toddlers aged between 17 to 30 months. It's designed for those who primarily speak one language and have not been diagnosed with any developmental delays or disorders.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in tasks to test word learning and generalization abilities using digital media
Follow-up
Participants are monitored for vocabulary growth and retention after the tasks
Treatment Details
Interventions
- Modality - 2D-2D
- Modality - 2D-3D
- Modality - 3D-2D
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oklahoma State University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator